Similar articles

• Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression.

  Hu J, Wang SG, Hou Y, Chen Z, Liu L, Li R, Li N, Zhou L, Yang Y, Wang L, Wang L, Yang X, Lei Y, Deng C, Li Y, Deng Z, Ding Y, Kuang Y, Yao Z, Xun Y, Li F, Li H, Hu J, Liu Z, Wang T, Hao Y, Jiao X, Guan W, Tao Z, Ren S, Chen K. Hu J, et al. Nat Genet. 2024 Mar;56(3):442-457. doi: 10.1038/s41588-024-01662-5. Epub 2024 Feb 15. Nat Genet. 2024. PMID: 38361033 Free PMC article.
• Metabolic reprogramming in renal cancer: Events of a metabolic disease.

  Chakraborty S, Balan M, Sabarwal A, Choueiri TK, Pal S. Chakraborty S, et al. Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188559. doi: 10.1016/j.bbcan.2021.188559. Epub 2021 May 6. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33965513 Free PMC article. Review.
• MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.

  Liu Y, Qi L, Ye B, Wang A, Lu J, Qu L, Luo P, Wang L, Jiang A. Liu Y, et al. Cancer Biol Ther. 2024 Dec 31;25(1):2345977. doi: 10.1080/15384047.2024.2345977. Epub 2024 Apr 24. Cancer Biol Ther. 2024. PMID: 38659199 Free PMC article.
• Single-cell multi-omics reveals that FABP1 + renal cell carcinoma drive tumor angiogenesis through the PLG-PLAT axis under fatty acid reprogramming.

  Wang Y, Liang Y, Li M, Lu J, Zhou S, Yu Y, Yang C, Hou X. Wang Y, et al. Mol Cancer. 2025 Jun 16;24(1):179. doi: 10.1186/s12943-025-02377-9. Mol Cancer. 2025. PMID: 40518526 Free PMC article.
• Chromophobe renal cell carcinoma: New genetic and metabolic insights.

  Zhang L, Henske EP. Zhang L, et al. Urol Oncol. 2020 Aug;38(8):678-681. doi: 10.1016/j.urolonc.2020.04.035. Epub 2020 May 20. Urol Oncol. 2020. PMID: 32444178 Review.